1st Quarter - Report

FAEGRE DRINKER BIDDLE & REATH LLP for INTERNATIONAL PHARMACEUTICAL AEROSOL CONSORTIUM

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Environment/Superfund ENV

Montreal Protocol on Substances that Deplete the Ozone Layer Climate Change

Foreign entity interest: Implications for medical uses of aerosol propellants (i.e., hydrofluorocarbons and chlorofluorocarbons).

LobbyistCovered position, as disclosed
MAUREEN HARDWICK —

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTRAZENECA United Kingdom United Kingdom — $1,430
GLAXOSMITHKLINE SERVICES United Kingdom United Kingdom — $1,430
CHIESI FARMACEUTICI S.P.A. Italy Italy — $1,430

Affiliated organisations

OrganisationLocation
ABBOTT LABORATORIES North Chicago, IL, US
ASTRAZENECA Leicestershire, LE11 5R, GB
BOEHRINGER INGELHEIM Washington,, DC, US
CHIESI FARMACEUTICI S.P.A. I-43100 Parma, IT
GLAXOSMITHKLINE SERVICES UNLIMITED Gloucestershire GL17, GB
INYX INC. New York, NY, US
SEPRACOR INC. Marlborough, MA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.